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Summary: Microscopically detectable asymptomatic P. vivax and P. falciparum infections form the 
most important source of onward mosquito infections in a low-endemic setting in Ethiopia. P. vivax 
symptomatic infections are highly infectious but less prevalent and thereby contribute less to 
transmission. 
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ABSTRACT 
Background: The majority of P. vivax and P. falciparum infections in low-endemic settings are 
asymptomatic. The relative contribution to the infectious reservoir of these infections, often of low-
parasite-density, compared to clinical malaria cases, is currently unknown but important for malaria 
elimination strategies.  
Methods: We assessed infectivity of passively-recruited symptomatic malaria patients (n=41) and 
community-recruited asymptomatic individuals with microscopy- (n=41) and PCR-detected 
infections (n=82) using membrane feeding assays with Anopheles arabiensis mosquitoes in Adama, 
Ethiopia. Malaria incidence and prevalence data was used to estimate the contributions of these 
populations to the infectious reservoir. 
Results: Overall, 34.9% (29/83) of P. vivax and 15.1% (8/53) P. falciparum infected individuals 
infected ≥1 mosquitoes. Mosquito infection rates were strongly correlated with asexual parasite 
density for P. vivax (ρ = 0.63; P < .001) but not for P. falciparum (ρ = 0.06; P = .770). P. vivax 
symptomatic infections were more infectious to mosquitoes (infecting 46.5% of mosquitoes, 
307/660) compared to asymptomatic microscopy-detected (infecting 12.0% of mosquitoes, 80/667; 
P = .005) and PCR-detected infections (infecting 0.8% of mosquitoes, 6/744; P < .001). Adjusting for 
population prevalence, symptomatic, asymptomatic microscopy- and PCR-detected infections were 
responsible for 8.0%, 76.2% and 15.8% of the infectious reservoir for P. vivax, respectively. For P. 
falciparum, mosquito infections were sparser and also predominantly from asymptomatic infections.  
Conclusions: In this low-endemic setting aiming for malaria elimination, asymptomatic infections are 
highly prevalent and responsible for the majority of onward mosquito infections. The early 
identification and treatment of asymptomatic infections might thus accelerate elimination efforts. 
 
Key words: malaria, infectiousness, reservoir, submicroscopic, elimination 
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INTRODUCTION 
Malaria continues to be a major public health problem, with 212 million cases and 429,000 deaths in 
2015 [1]. Despite this sobering figure, considerable reductions in incidence occurred over the last 
decade. In areas with low or declining transmission intensity, infections are commonly present at 
low parasite densities that may be undetectable by conventional rapid diagnostic tests (RDT) and 
microscopy [2]. These infections generally do not elicit symptoms and may persist for several 
months [3]. Although there is increasing evidence that these asymptomatic infections may have 
health consequences for the infected host [4], their main importance may lie in sustaining onward 
malaria transmission.  
Malaria transmission depends on the presence of mature gametocytes in the peripheral blood. The 
production of gametocytes from their asexual progenitors differs between Plasmodium species. In P. 
vivax gametocyte generation begins early during infection with gametocytes appearing in the 
bloodstream 2 – 3 days after the first asexual parasites and typically disappearing within 3 days after 
asexual infections are cleared [5]. In contrast, mature P. falciparum gametocytes first appear 10 – 12 
days after asexual parasites and may circulate for several weeks after asexual parasites have been 
cleared [6]. As a result, gametocyte density is closely associated with asexual parasite density in P. 
vivax [7] whilst this association is weaker for P. falciparum [6, 8]. 
Because of the rapid production of gametocytes and the relatively long period between infection 
and symptoms [9], many P. vivax infections may be infectious to mosquitoes  before  clinical 
presentation at health facilities [10]. There is inconclusive evidence on the infectivity of 
asymptomatic P. vivax infections [10-12]. By comparison, considerably more data are available on 
the infectiousness of asymptomatic parasite carriers for P. falciparum. These data almost exclusively 
come from highly-endemic African settings. In those settings, asymptomatic infections, including 
those undetectable by microscopy or RDT [13], frequently result in onward transmission to 
mosquitoes although this has not been directly compared with the transmission from symptomatic 
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infections [14]. Importantly, a study from a low-endemic setting in Asia suggested that symptomatic 
patients with microscopically detectable gametocytes formed the most important source of P. 
falciparum mosquito infection [15]. These contrasting findings highlight the necessity to directly 
assess the relative contribution of symptomatic and asymptomatic infections to onward 
transmission to mosquitoes. These data  are particularly relevant for low transmission and 
elimination settings to inform policy on the added value of specifically targeting (low-density) 
asymptomatic infections [16]. 
Here, we present the first study to directly quantify the relative contribution to malaria transmission 
of symptomatic malaria patients and asymptomatic microscopy-detected or PCR-detected P. 
falciparum and P. vivax infections in a low-endemic setting in Ethiopia.  
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MATERIAL & METHODS 
Study area and population 
This study was conducted in Adama district (woreda), in the Oromia Region, ~100km southeast of 
Addis Ababa. Both P. falciparum and P. vivax are endemic in the district with transmission peaking 
following the two rainy seasons in September – November (major season) and April – May (short 
season). Anopheles arabiensis is the dominant vector in Ethiopia [17]. 
Symptomatic and asymptomatic malaria-infected individuals were recruited simultaneously in 
October – December 2016 (Figure 1). Self-presenting microscopy-detected P. falciparum and P. vivax 
malaria patients were passively recruited at the malaria clinic in Adama city. Asymptomatic malaria 
infections were recruited from the community of the Batu Degaga kebelle, an administrative unit 
located within Adama woreda (1,440 – 1,580 meters). Written informed consent was obtained from 
all participants and/or parents or guardians. This study received approval from the ethics review 
boards of Addis Ababa University (CNSDO/264/08/16), Jimma University (RPGC/395/06), Armauer 
Hansen Research Institute (PO52/14), the National Research Ethics Review Committee 
(310/109/2016) and the London School of Hygiene & Tropical Medicine (10628). 
Parasitology 
Finger prick blood samples were collected from clinical patients and during screening of community 
members. This sample was used for microscopy and to prepare dried blood spots (DBS) [18]. 
Microscopic investigation was done by two expert microscopists, each screening 100 microscopic 
fields before declaring a slide negative. 18S based nested PCR (nPCR) [19] was done in the field to 
inform feeding assays (Figure 1). A MagNAPure LC automatic extractor (Roche Applied Science) was 
used to extract DNA from DBS collected at the moments of screening and membrane feeding for 18S 
based qPCR and total nucleic acids from 100µl venous blood samples collected in RNAprotect at the 
moment of membrane feeding. qRT-PCR for gametocytes was performed, targeting Pvs25 and Pfs25 
mRNA for female P. vivax and P. falciparum gametocytes, respectively on DNase treated material 
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[18] and PfMGET mRNA for male P. falciparum gametocytes without prior DNase treatment [20]. Full 
details on nucleic acid extraction and molecular assays are provided in the supplemental information 
(Supplemental note 1). 
Assessment of infectivity by mosquito membrane feeding 
Symptomatic patients, asymptomatic microscopy- and nPCR-detected community-members were 
invited to participate in feeding assays on the day of diagnosis, within 1 – 5 and 13 – 40 days, 
respectively (Figure 1). Following sampling for feeding experiments and molecular analyses, malaria-
infected individuals were treated according to national guidelines [21]. Membrane feeding assays 
were conducted following an established protocol [22] using 2 – 6 days old female An. arabiensis 
mosquitoes that were locally reared at 26 – 30oC and 60 – 80% humidity. 1 – 2 day old mosquitoes 
were transported from the insectary in Sekoru to Adama (~350km) in humidity and temperature 
maintained containers and allowed to acclimatize for one day prior to experiments. Fully fed 
mosquitoes were provided with glucose for 12 days when they were frozen with desiccant at -80oC. 
Mosquitoes that fed on qPCR confirmed parasite positive blood samples were homogenized by 
bead-beating and tested for infection by circumsporozoite protein based ELISA followed by 
confirmation with 18S based qPCR [23]. 
Analysis 
Symptomatic malaria was defined as microscopy-detected malaria (at any density) in the presence of 
measured fever or reported fever in the last 48 hours. Asymptomatic malaria infections were 
defined as microscopy- or PCR-detected infections without reported symptoms. These categories 
were defined at enrolment, i.e. the time of presentation with symptomatic malaria at the clinic or 
the time-point of the community survey when an asymptomatic malaria infection was detected. 
Parasite densities fluctuated during the time-window between enrolment and mosquito feeding 
such that PCR-detected infections became detectable by microscopy at the time of feeding. Since 
these infections were undetectable by microscopy during the community survey, we nevertheless 
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classified these as asymptomatic PCR-detected infections. Statistical analyses were performed using 
STATA 13 (StataCorp., TX, USA) and Graph Pad Prism 5.0 (Graph Pad Software Inc., CA, USA). Mann-
Whitney tests and unpaired student’s t-tests were used for continuous variables. Spearman’s rank 
correlation coefficient (ρ) was used for correlations between continuous variables. Proportions were 
compared by Pearson’s 𝜒2 test or Fisher’s exact test. The detectability and contribution to the 
infectious reservoir of individuals in each of the three categories (symptomatic, asymptomatic 
microscopy- and PCR-detected infections) for both falciparum and vivax were estimated by 
calculating the proportion of infected individuals in each infection category that are detectable for a 
range of diagnostic thresholds [14]. The expected proportion of infected individuals that would be in 
each category in a cross-section of a population was estimated using incidence data from the district 
(Supplemental note 2), and the prevalence of the asymptomatic categories estimated directly from 
the data. The proportion of the infectious reservoir attributable to each category and to different 
parasite densities was calculated as the proportion of the infected population in each category 
weighted by the relative infectivity to mosquitoes of each category (Supplemental note 3) [14]. The 
detectability of P. vivax infections in relation to copy number (Supplemental note 4) and 
uncertainties in P. vivax clinical incidence estimates (Supplemental note 5) were incorporated in 
these estimates. 
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Results 
During the three month study period 41 individuals reported to the clinic with symptomatic 
microscopy-confirmed malaria. Out of 490 individuals who participated in community surveys 8.6% 
(42/490) were malaria parasite positive by microscopy and 98 additional individuals were positive by 
nPCR (Table 1). The majority of microscopy-detected infections were PCR-confirmed (Table 1). 
Symptomatic patients were on average older than asymptomatically infected individuals detected in 
community surveys (P < .001; Table 1) and were more likely to be male (P < .001; Table 1).  
Parasite densities in clinical and asymptomatic infections at enrolment 
P. vivax 18S copy numbers by qPCR were highest in clinical malaria infections (median, 23,139.6 
copies/μl; interquartile range [IQR], 12,268.9 – 52,479.0; P < .001) followed by microscopy-detected 
asymptomatic infections (median, 550.1; IQR, 169.5 – 1,821.3) and PCR-detected asymptomatic 
infections (median, 65.7; IQR, 43.9 – 184.8; Figure 2A). Similarly, P. falciparum qPCR parasite density 
was highest in clinical malaria infections (median, 7,190.6 parasites/µl; IQR, 674.5 – 12,721.1) 
followed by microscopy-detected asymptomatic infections (median, 189.9; IQR, 67.1 – 380.1; P = 
.024) and PCR-detected asymptomatic infections (median, 4.0; IQR, 1.7 – 42.4; P < .001; Figure 2B).  
Gametocyte carriage and infectiousness to mosquitoes  
At the time of membrane feeding, female gametocytes were detected by qRT-PCR in 92.8% (77/83) 
of P. vivax qPCR positive individuals (Table 2); gametocyte density being positively associated with 
total parasite density (Figure 2C; ρ = .87; P < .001). P. falciparum male and/or female gametocytes 
were detected by qRT-PCR in 56.6% (30/53) of P. falciparum qPCR positive individuals (Table 2). No 
association was observed between P. falciparum qPCR parasite density and qRT-PCR gametocyte 
density at the moment of feeding (Figure 2D; ρ = .02; P = .889). 
In 164 membrane-feeding experiments, a total of 8,936 mosquitoes were successfully fed (median of 
56 per experiment; IQR, 39 – 66). Of the mosquitoes that survived until day 12 post-feeding (median 
survivorship, 67.4%; IQR, 47.2 – 80.5%) a minimum of 20 mosquitoes were examined per experiment 
on qPCR positive individuals (123 experiments). The number of successful membrane-feeding 
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experiments (Figure 1) is lower than the original study population in Table 1 because some 
individuals were qPCR negative at the time of membrane feeding (n = 23), others did not consent to 
donate venous blood during feeding (n = 17), or had <20 surviving mosquitoes (n = 18). 
Of individuals infected with P. vivax, 34.9% (29/83) infected ≥1 mosquito and 19.0% (393/2,071) of 
all mosquitoes became infected. Infectious individuals (i.e. individuals who infected at least one 
mosquito) infected a mean of 49.0% (range, 5 – 96%) of mosquitoes (Table 2, Table S1 and Table S2). 
Strong positive associations were observed between the proportion of infected mosquitoes and P. 
vivax parasite (ρ = .63; P < .001) and gametocyte (ρ = .72; P < .001) densities (Figure 3A and 3B; 
Figure S1). Of P. falciparum infected individuals 15.1% (8/53) infected ≥1 mosquitoes, with 0.8% 
(13/1,703) of all mosquitoes becoming infected. Infectious individuals infected a mean of 7.8% 
(range, 1.7 – 29.4%) mosquitoes (Table 2, Table S1 and Table S3). While there was no difference in P. 
falciparum asexual parasite densities between infectious and non-infectious individuals, 
infectiousness was positively associated with both female (ρ = .42, P = .024) and male (ρ = .42; P = 
.044) gametocyte densities (Figure 3C and 3D; Figure S2). No significant difference was observed in 
the duration of symptoms and hemoglobin level between infectious and non-infectious groups for 
both species (Table 1). A large fraction of infectious individuals for both P. vivax (72.4%; 21/29) and 
P. falciparum (50.0%; 4/8) were above 15 years of age.   
Relative contribution to the infectious reservoir 
Parasite prevalence and density fluctuated in the time-period between the initial community 
screening and membrane feeding (Supplemental note 6). Because the initial community screening 
best reflects the detectability of infections during single-round screening efforts, the classification of 
infections at screening (Table 1) was maintained in all analyses. These recruitment parasite densities 
differed between P. vivax clinical malaria cases, asymptomatic microscopy- and PCR-detected 
infections (Figure 4A). The probability of detection by microscopy as a function of the P. vivax copy 
number (Supplemental note 4) indicated that infections with ≥584 copies/μl had 80% probability of 
detection by microscopy. Three detection thresholds were used in the analysis shown in Figure 4B – 
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4D (97, 584 and 4925 copies/μl, corresponding to 50%, 80% and 95% probability of detection by 
microscopy). The estimated number of clinical malaria cases per 1,000 people/year was 27.6 for P. 
vivax and 28.8 for P. falciparum (Supplemental notes 2 & 5). Accordingly, clinical P. vivax cases, 
asymptomatic microscopy- or PCR-detected infections were estimated to be responsible for 8.0%, 
76.2% and 15.8% of the infectious reservoir, respectively (Figure 4D). A diagnostic with a sensitivity 
of 584 copies/μl would detect 90.7% of the infectious reservoir (Figure 4D). If we assume prevalence 
of asymptomatic microscopy- and PCR-detected infections would be at the lower end of the 95% 
confidence intervals around their estimated prevalence and assume a higher clinical incidence 
(Supplemental note 5), clinical P. vivax cases, asymptomatic microscopy- and PCR-detected 
infections would be responsible for 30.4%, 56.0% and 13.6% of the infectious reservoir, respectively. 
For P. falciparum fewer mosquito infections were observed and estimates are less precise. Based on 
the available data, clinical cases, asymptomatic microscopy- or PCR-detected infections were 
estimated to be responsible for 0.8%, 69.5% and 29.7% of the infectious reservoir for P. falciparum, 
respectively (Figure S3). 
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Discussion 
In the current study, we directly quantified the relative contribution to the infectious reservoir of 
clinical malaria cases and microscopy- and PCR-detected asymptomatic P. vivax and P. falciparum 
malaria-infected individuals. Whilst symptomatic P. vivax patients were highly infectious, their 
contribution to the infectious reservoir was limited as a consequence of the much larger population 
of asymptomatically infected individuals. Compared to P. vivax, a smaller fraction of P. falciparum-
infected individuals were infectious to mosquitoes; P. falciparum mosquito infections were 
predominantly observed from asymptomatically infected individuals.  
The majority of malaria infections that are detected across endemic settings are not associated with 
clinical symptoms that elicit treatment-seeking behavior [2]. The contribution of these asymptomatic 
infections to transmission is a matter of current debate [24]. In P. vivax the level of parasitaemia was 
strongly correlated with gametocyte density [7, 25] and, as a consequence, the probability of 
mosquito infection [10, 26]. Symptomatic P. vivax malaria cases with high parasite densities were 
highly infectious in the present study (46.5% of mosquitoes infected). We observed a sharp increase 
in the proportion of mosquito infections at microscopically detected parasite densities, in agreement 
with a recent study from Thailand [10]. In line with this study PCR-detected infections were unlikely 
to infect mosquitoes; only one individual who was microscopy-negative but PCR-positive during 
screening was infectious to mosquitoes (3% of mosquitoes infected). That single infection was 
microscopically detectable at the time of mosquito feeding, reflecting temporal fluctuation in 
parasite densities that impact on the likelihood that infections are detected by different diagnostics. 
Because the infection was missed during the community survey, the individual was nevertheless 
classified as a PCR-detected asymptomatic infection. Importantly, we observed that mosquito 
infections were common from asymptomatic microscopy-detected infections (12% of mosquitoes 
infected). The relative infectiousness of these individuals increases when considering their relative 
prevalence in the population. The prevalence of symptomatic infections among the total population 
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was relatively low in the study area based on national and local  malaria incidence data [27]. An 
estimated 0.1 – 3.9% of all P. vivax infected individuals were found to be symptomatic at any given 
time during the peak transmission season; making the contribution of the symptomatic group to the 
overall infectious reservoir relatively small (8.0% as best estimate from the study data; 30.4% as 
upper estimate from a simple sensitivity analysis). In contrast with the study by Kiattibutr et al. [10], 
where all asymptomatic infections had parasite densities below the microscopic threshold for 
detection and contributed very little to transmission, 8.6% of the population was microscopy 
parasite positive in our survey and 20.1% by nPCR. These two categories of asymptomatically 
infected individuals were responsible for approximately 76.2% (microscopy-detected) and 15.8% 
(PCR-detected) of the total infectious reservoir. Mosquito infection rates were generally low for P. 
falciparum and, similar to P. vivax, clinical malaria cases had a modest contribution to mosquito 
infections. The low infectivity of P. falciparum infections is most likely related to the low parasite and 
gametocyte densities in our population. Similar to our findings, only 10.1% of qPCR positive 
individuals in a high-endemic site in Burkina Faso and 2.9% in a low-endemic site in coastal Kenya 
were infectious to mosquitoes, and the proportion of infected mosquitoes increased rapidly at 
densities >10 female gametocytes/µl [28]. A study in Cambodia concluded that most mosquito 
infections are caused by high-density gametocyte carriers and asymptomatic low-density infections 
may be less relevant for transmission [15]. Our findings, although based on a small number of 
infectious P. falciparum infected individuals, are in line with other findings from African settings that 
indicate that a non-negligible fraction of mosquito infections arise from asymptomatic infections, 
including asymptomatic PCR-detected infections [29]. Competency of vectors, A. dirus in the 
Cambodia study and A. arabiensis in our study, might form an explanation for the observed 
differences and is highly  relevant in estimating the infectivity of low-density infections in different 
geographical settings [30].  
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Although our study was conducted in one site and season, and few P. falciparum infections resulted 
in onward transmission to mosquitoes, our findings are of relevance for malaria control and 
elimination initiatives. Asymptomatic infections formed an important source of mosquito infections 
in this low-endemic setting. It is conceivable that efforts that identify and target these infections 
would accelerate malaria elimination efforts [31]; it is unclear whether these asymptomatic 
infections initially elicited symptoms that would have allowed their detection by enhanced case 
management. Although this study was not powered to assess temporal dynamics of detectability 
and parasite densities, our repeated assessments of parasite densities reaffirm that the detectability 
of infections fluctuates over time. Understanding the dynamics of (asymptomatic) infections in 
relation to parasite densities, relapses for P. vivax, gametocyte production and infectivity is needed 
to add a temporal element to the contribution of these individuals to the infectious reservoir. A high 
proportion of chronic infections that are transmissible over several weeks or months would add 
weight to suggestions that  asymptomatic infections need to be targeted in some transmission 
settings to achieve malaria elimination and more sensitive diagnostics are require to do this.  
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Table 1. Characteristics of study participants at enrolment 
Characteristics 
Symptomatic 
microscopy-detected  
Asymptomatic 
microscopy-detected 
Asymptomatic 
PCR-detected P-value 
Female sex, % (n/N) 12.2 (5/41) 52.4 (22/42) 44.9 (44/98) < .001* 
Age in years, Median (IQR) 25.5 (20.0 - 39.0) 9.5 (5.0 - 14.0) 13.0 (7.0 - 26.0) < .001
+
 
0 - 5 years, % (n/N) 0.0 (0/41) 28.6 (12/42) 23.5 (23/98) 
 5 - 15 years, % (n/N) 7.3 (3/41) 50.0 (21/42) 39.8 (39/98) 
 Above 15 years, % (n/N) 92.7 (38/41) 21.4 (9/42) 36.7 (36/98)   
Duration of symptoms,  
median days (IQR) 4(3,7) N/A N/A N/A 
Haemoglobin, g/dL, median 
(IQR) 13.4 (8.7 - 15.0) 12.8 (12.6 - 13.5) 
13.5 (12.2 - 
14.3) .426
+
 
Plasmodium spp. infection screening# N/A 
P. vivax, n (%) 29 24 (4.9) 53 (10.9) 
 P. falciparum, n (%) 9 8 (1.6) 38 (7.8) 
 Mixed species infection, n (%) 2 8 (1.6) 7 (1.4)   
IQR= 25th - 75th percentile; N/A = not available; At the moment of presentation with symptomatic malaria at the clinic and during screening of community-
recruited study participants infection status was determined by microscopy and subsequently confirmed with nPCR and qPCR#; the denominator for the 
asymptomatic PCR-detected infections was 487 as 3 DBS were missing while 490 individuals were screened by microscopy; values were compared between 
microscopy-detected symptomatic patients and community-recruited individuals (asymptomatic microscopy-detected and PCR-detected individuals 
combined), p-values were determined by Fischer's exact test* and the Mann-Whitney test+. Species identification by PCR failed in three microscopy positive 
infections where infections were only confirmed at generic level. 
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Table 2. Relative infectiousness of symptomatic and asymptomatic P. falciparum and P. vivax 
infected individuals. 
Status 
P. vivax infection, %(n/N) P. falciparum infection, %(n/N) 
Gametocyte 
positive 
individuals 
Infectious 
individuals 
Infected 
mosquitoes 
Gametocyte 
positive 
individuals 
Infectious 
individuals 
Infected 
mosquitoes 
Symptomatic 
microscopy-
detected 
100.0(25/25) 76.0(19/25) 46.5(307/660) 36.4(4/11) 9.1(1/11) 0.5(2/383) 
Asymptomatic 
microscopy-
detected 
96.4(27/28) 32.1(9/28) 12.0(80/667) 61.5(8/14) 28.6(4/14) 2.3(10/441) 
Asymptomatic 
PCR-detected 
83.3(25/30) 3.3(1/30) 0.8(6/744) 64.3(18/28) 10.7(3/28) 0.1(1/879) 
The denominators in the infectious individuals indicate experiments for which samples that were successfully processed for mosquito infection status. 
Experiments with fewer than 20 surviving mosquitoes on day 12 post feeding (n = 18) or with qPCR-negative participant blood samples at the time of 
experiments (n = 23) were not processed and do not appear in this table. Infection status was determined using parasitology results at the screening visit 
(asymptomatic infections) or the time of presentation at the clinic (symptomatic infections). Mixed species infections (2 symptomatic microscopy-detected 
infections; 7 asymptomatic microscopy-detected infections and 4 asymptomatic PCR-detected infections) appear in both P. vivax and P. falciparum results. 
More details are provided in the supplemental information.  
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Figure legends  
 
Figure 1. Patient and community recruitment strategies and assessments of infectivity. Mosquito 
feeding experiments were not done (*) either because participants were not available or did not 
consent to donate venous blood samples during the moment of feeding (n = 17). Mosquito 
infectivity experiments were disregarded (**) because of negative qPCR results during feeding (n = 
23) or survival of fewer mosquitoes on day 12 post feeding (n = 18). 
 
Figure 2. Plasmodium vivax and Plasmodium falciparum parasite and gametocyte densities in 
symptomatic patients and asymptomatically infected individuals.  Y-axes shows the Log10 
transformed P. vivax 18S copy numbers/µl (A) and P. falciparum parasite densities/µl (B) during the 
screening surveys at the clinic and in the community with status indicated on the X-axes. Presented 
in (C) and (D) are Log10 transformed P. vivax Pvs25 transcripts/µl (C) and Log10 transformed P. 
falciparum gametocytes/µl (D) in the Y-axes and Log10 transformed P. vivax 18S copy numbers/µl (C) 
and P. falciparum parasite densities/µl (D) during membrane feeding experiments. Data are 
presented for the three defined groups of clinical malaria cases (red circles) and asymptomatic 
microscopy-detected infections (orange circles) and asymptomatic PCR-detected (microscopy 
negative) infections (yellow circles). In (D) empty (unfilled) circles indicate male gametocytes 
whereas filled circles indicate female gametocytes. In this figure, each sample provides two 
observations for male and female gametocyte density. In A and B lines refer to the median parasite 
density and the inter-quartile ranges. 
 
Figure 3. Percentage of infected mosquitoes in relation to parasite (A and C) and gametocyte 
densities (B and D). Shown in the Y-axes are percentages of infected mosquitoes. Presented in the X-
axes are Log10 transformed copy numbers/µl of the 18S rRNA gene (A) and Pvs25 transcripts/µl (B) of 
P. vivax parasites and P. falciparum parasites/µl (C), P. falciparum female (filled circles) and male 
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(unfilled circles) gametocytes/µl (D) measured on samples collected at the moment of feeding. In 
panel D, each sample contributes two observations, for male and female gametocyte density. Red 
circles are microscopy-detected symptomatic infections; orange circles are asymptomatic 
microscopy-detected infections; and yellow circles are PCR-detected asymptomatic infections. 
 
Figure 4. Contribution of symptomatic patients and asymptomatically infected individuals to the 
infectious reservoir and the detectability of P. vivax infections. In all panels, dark red, orange and 
yellow indicate individuals with clinical malaria cases, asymptomatic microscopy-detected infection 
and asymptomatic PCR-detected infections respectively. (A) Smoothed histograms showing the P. 
vivax 18S copy numbers/µl of individuals in each category. (B) The proportion of individuals in each 
category that would be detected for diagnostics with different detection limits based on P. vivax 18S 
copy numbers/µl (X-axis). The three vertical dashed grey lines indicate the P. vivax copy number 
associated with a 50% 80% and 95% probability (left to right) of detection by microscopy. These 
correspond to values of 87, 584 and 4925 copies/µl (left to right) and were obtained using a logistic 
regression model with detectability by microscopy as the dependent variable and P. vivax 18S copy 
numbers/µl as the independent variable (this also applies to the three vertical lines in 5B and 5D). 
Details of the regression model are provided in the Supplemental note 4. The proportion of each 
histogram that is to the right of these lines indicates the fraction of individuals in this category that is 
detected by a diagnostic with this sensitivity. (C) The proportion of the infected population in each 
category (X-axis) and the infectiousness to mosquitoes of each category (Y-axis). (D) The contribution 
to the infectious reservoir of individuals in each category in relation to P. vivax 18S copy numbers/µl. 
Clinical cases, asymptomatic microscopy-detected and PCR-detected infections are responsible for 
8.0%, 76.2% and 15.8% of the infectious reservoir, respectively. At different diagnostic detection 
limits, different fractions of the total infectious reservoir are detected: for example, with a limit of 
detection of 584 copies/µl 90.7% of the infectious reservoir is detected. Details on the calculations 
for 4D are presented in the Supplemental note 3. 
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Figure 1. 
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Figure 3. 
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Figure 4. 
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